# US 2019/0375702 A1 · A novel process for the synthesis of 1-aryl-1-trifluoromethylcyclopropanes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0375702 A1
- Document ID: US20190375702A1
- Status: Published application
- Kind: A1
- Application number: 16/483,247
- Filed: 2018-02-05
- Published: 2019-12-12
- Earliest claimed: 2017-02-06
- Assignees: Idorsia Pharmaceuticals Ltd
- Applicants: Idorsia Pharmaceuticals Ltd
- Inventors: Lee MCLAREN; Daniel TO; David TOVELL; Stefan ABELE
- Web page: https://patentgrep.com/patent/US20190375702A1

## CPC

- C07C 51/363: by introduction of halogen; by substitution of halogen atoms by other halogen atoms
- C07C 17/093: by replacement by halogens
- C07C 51/38: by decarboxylation
- C07C 57/58: containing six-membered aromatic rings
- C07C 57/62: containing six-membered aromatic rings and other rings
- C07C 67/343: by increase in the number of carbon atoms
- C07C 51/09: from carboxylic acid esters or lactones
- C07C 69/65: of unsaturated acids
- C07C 2601/02: with a three-membered ring
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS

## Abstract

The present invention relates to a process for the manufacturing of 1-aryl-1-trifluoromethylcyclopropanes, which serve as intermediates for the manufacturing of calcium T channel blockers of the general formula (A) which are described in WO 2015/186056.

## Claims

### Claim 1

A process for the manufacturing of the compound of formula (I)
said process comprising the reaction of a compound of formula (II)
wherein R1 is H or Br,
with SF4 and HF, to give a compound of formula (III)
wherein R1 is H or Br.

### Claim 2 (depends on 1)

The process according to claim 1, wherein R1 is H.

### Claim 3 (depends on 1)

The process according to claim 1, wherein R1 is Br.

### Claim 4 (depends on 1)

The process according to claim 1, wherein dicloromethane is used as solvent.

### Claim 5 (depends on 1)

The process according to claim 1, wherein SF4 is added in an amount of 2 to 10 equivalents.

### Claim 6 (depends on 1)

The process according to claim 1, wherein R1 is H and the amount of HF is from 0.4 to 2.5 equivalents.

### Claim 7 (depends on 1)

The process according to claim 1, wherein R1 is Br and the amount of HF is from 1.5 to 2.5 equivalents.

### Claim 8 (depends on 1)

The process according to claim 1, said process comprising the reaction of a compound of formula (III)
wherein R1 is Br, with
to give a compound of formula (V)
wherein R2 is methyl, ethyl, isopropyl, n-butyl, or benzyl.

### Claim 9 (depends on 8)

The process according to claim 8, wherein R2 is methyl.

### Claim 10 (depends on 8)

The process according to claim 8, further comprising K3PO4, Pd(OAc)2 and 2-biphenyl)-di-tert-butylphosphine.

### Claim 11 (depends on 8)

The process according to claim 8, comprising one of the following steps a orb:
a) treatment of the compound of formula (V), wherein R2 is methyl, ethyl, isopropyl, n-butyl, or benzyl,
a1) with NaOH solution, followed by
a2) treatment with HCl at 75-100° C.; or
b) treatment of the compound of formula (V), wherein R2 is methyl, ethyl, isopropyl, n-butyl, or benzyl,
b1) with NaOH solution, followed by treatment with HCl at 15-30° C. to obtain an intermediate product of formula (VII)
b2) followed by decarboxylation with HCl at 75-100° C. to obtain the product of formula (I).

### Claim 12

A process for the manufacturing of the compound of formula (III)
said process comprising the reaction of a compound of formula (II)
wherein R1 is H or Br, with SF4 and HF.

### Claim 13 (depends on 12)

The process according to claim 12, wherein dichloromethane is used as a solvent.

### Claim 14 (depends on 12, 13)

The process according to claim 12 or 13, wherein SF4 is added in an amount of 2.7 to 10 equivalents.

### Claim 15 (depends on 12)

The process according to claim 12, wherein R1 is H, and the amount of HF is from 0.4 to 2.5 equivalents.

### Claim 16 (depends on 12)

The process according to claim 12, wherein R1 is Br, and the amount of HF is from 1.5 to 2.5 equivalents.

### Claim 17

A compound of formula (Va)
wherein R2 is methyl, ethyl, isopropyl, n-butyl, benzyl or H, or a salt of said compound.

### Claim 18 (depends on 1, 17)

Use of the compound of formula (Va) according to claim 17, or a salt thereof, in a process for manufacturing the compound of formula (I) as defined in claim 1, or a salt thereof.
